Reglagene gets crucial TCA Orange County funding for FDA brain cancer therapy studies

Reglagene, Inc., researching breakthrough treatments for brain diseases, received a key investment from nationally known Tech Coast Angels (TCA) Orange County, allowing the firm to advance critical studies required by the U.S. Food and Drug Administration (FDA).

“TCA Orange County invested in our future,” said Richard Austin, Ph.D., Reglagene’s CEO. “This internationally respected group did very thorough diligence on our company before deciding it was a wise investment. In addition to the appreciation for the medical advances and life-changing benefits from our work, it’s also nice to be recognized as a solid investment for financial return.”

Read more here